• cortexyme (nasdaq:crtx) share price passes above 200 day moving average - here's why MarketBeat Tue, 28 Oct 2025 07:50:04 GMT
• cortexyme (nasdaq:crtx) share price passes above 200 day moving average - what's next? MarketBeat Fri, 10 Oct 2025 09:59:33 GMT
• Peninsula biotech lands big NIH grant to target common mouth bacteria at center of Alzheimer's disease The Business Journals Wed, 08 Oct 2025 07:00:00 GMT
• head-to-head review: allovir (nasdaq:alvr) versus cortexyme (nasdaq:crtx) Defense World Sat, 04 Oct 2025 06:01:32 GMT
• periodontal disease market: insights into epidemiology, available therapies, and key players | delveinsight | vaxcyte, angiolab, c... Barchart.com Wed, 24 Sep 2025 07:00:00 GMT
• cortexyme (nasdaq:crtx) share price passes above 200 day moving average – here’s what happened Defense World Tue, 23 Sep 2025 07:33:52 GMT
• head to head review: alpha cognition (otc:acogf) vs. cortexyme (nasdaq:crtx) Defense World Thu, 18 Sep 2025 06:49:01 GMT
• cortexyme (nasdaq:crtx) stock price crosses above 200 day moving average – here’s what happened Defense World Tue, 19 Aug 2025 10:20:22 GMT
• reviewing protalix biotherapeutics (nyse:plx) & cortexyme (nasdaq:crtx) Defense World Tue, 12 Aug 2025 07:00:00 GMT
• cortexyme files 8k - director, officer or compensation filing >crtx 富途牛牛 Mon, 04 Aug 2025 06:43:34 GMT
• critical contrast: nkgen biotech (nyse:nkgn) & cortexyme (nasdaq:crtx) Defense World Sat, 02 Aug 2025 05:11:10 GMT
• cortexyme (nasdaq:crtx) stock crosses above 200 day moving average – should you sell? Defense World Tue, 17 Jun 2025 07:41:15 GMT
• cortexyme, inc. investigated by block & leviton for potential securities law violations; investors who have lost money are encoura... ACCESS Newswire Fri, 09 May 2025 08:24:43 GMT
• cortexyme (nasdaq:crtx) share price crosses above 200 day moving average – should you sell? Defense World Sat, 15 Mar 2025 07:00:00 GMT
• contrasting agenus (nasdaq:agen) and cortexyme (nasdaq:crtx) Defense World Mon, 10 Mar 2025 07:00:00 GMT
• cortexyme (nasdaq:crtx) shares pass above two hundred day moving average – what’s next? Defense World Fri, 07 Mar 2025 08:00:00 GMT
• financial comparison: cardiol therapeutics (nasdaq:crdl) versus cortexyme (nasdaq:crtx) Defense World Thu, 06 Mar 2025 08:00:00 GMT
• contrasting cortexyme (nasdaq:crtx) and anavex life sciences (nasdaq:avxl) Defense World Fri, 28 Feb 2025 08:00:00 GMT
• The Cause of Alzheimer's Might Be Coming From Inside Your Mouth ScienceAlert Fri, 21 Feb 2025 08:00:00 GMT
• the cause of alzheimer's might be coming from inside your mouth ScienceAlert Thu, 20 Feb 2025 14:01:19 GMT
• cortexyme (nasdaq:crtx) stock price passes above two hundred day moving average – here’s what happened Defense World Tue, 18 Feb 2025 08:00:00 GMT
• cortexyme (nasdaq:crtx) shares cross above two hundred day moving average - here's what happened MarketBeat Tue, 11 Feb 2025 11:32:11 GMT
• cortexyme (nasdaq:crtx) share price crosses above 200 day moving average - here's what happened MarketBeat Tue, 11 Feb 2025 08:00:00 GMT
• cortexyme (nasdaq:crtx) shares pass above two hundred day moving average - here's what happened MarketBeat Sat, 08 Feb 2025 15:05:40 GMT
• cortexyme (nasdaq:crtx) stock passes above 200-day moving average - here's why MarketBeat Sat, 08 Feb 2025 15:05:40 GMT
• cortexyme (nasdaq:crtx) stock price crosses above 200-day moving average - should you sell? MarketBeat Sat, 08 Feb 2025 15:05:40 GMT
• cortexyme (nasdaq:crtx) stock price crosses above two hundred day moving average – here’s why Defense World Fri, 31 Jan 2025 08:00:00 GMT
• cortexyme (nasdaq:crtx) stock price crosses above two hundred day moving average – here’s what happened Defense World Thu, 23 Jan 2025 08:00:00 GMT
• cortexyme (nasdaq:crtx) stock crosses above 200 day moving average - what's next? MarketBeat Thu, 23 Jan 2025 07:49:59 GMT
• cortexyme (nasdaq:crtx) shares cross above 200-day moving average – here’s why Defense World Wed, 15 Jan 2025 08:39:22 GMT
• cortexyme (nasdaq:crtx) shares pass above 200 day moving average - here's why MarketBeat Wed, 15 Jan 2025 08:33:40 GMT
• cortexyme (nasdaq:crtx) stock price crosses above two hundred day moving average - should you sell? MarketBeat Tue, 07 Jan 2025 08:00:00 GMT
• cortexyme (nasdaq:crtx) vs. prokidney (nasdaq:prok) head to head comparison Defense World Thu, 02 Jan 2025 08:00:00 GMT
• cortexyme (nasdaq:crtx) stock crosses above two hundred day moving average – should you sell? Defense World Sat, 28 Dec 2024 08:00:00 GMT
• cortexyme (nasdaq:crtx) stock crosses above 200 day moving average - here's what happened MarketBeat Sat, 28 Dec 2024 08:00:00 GMT
• cortexyme (nasdaq:crtx) stock price crosses above 200-day moving average – here’s what happened Defense World Fri, 20 Dec 2024 09:00:03 GMT
• cortexyme (nasdaq:crtx) stock passes above 200-day moving average - should you sell? MarketBeat Fri, 20 Dec 2024 08:49:55 GMT
• cortexyme (nasdaq:crtx) share price passes above 200-day moving average - time to sell? MarketBeat Fri, 20 Dec 2024 08:00:00 GMT
• head-to-head comparison: evaxion biotech a/s (nasdaq:evax) versus cortexyme (nasdaq:crtx) Defense World Thu, 12 Dec 2024 06:05:05 GMT
• cortexyme (nasdaq:crtx) stock crosses above 200-day moving average - should you sell? MarketBeat Sat, 09 Nov 2024 09:42:54 GMT
• cortexyme stock hits 52-week low at $0.63 amid market challenges Investing.com Tue, 13 Aug 2024 07:00:00 GMT
• immunitybio (nasdaq:ibrx) versus cortexyme (nasdaq:crtx) head to head analysis American Banking and Market News Fri, 12 Jul 2024 07:00:00 GMT
• critical comparison: immunitybio (nasdaq:ibrx) vs. cortexyme (nasdaq:crtx) Defense World Wed, 10 Jul 2024 07:00:00 GMT
• cortexyme to present at investor conferences in june 2021 Quantisnow Tue, 02 Jul 2024 19:27:07 GMT
• cortexyme announces pipeline update and anticipated 2021 milestones Quantisnow Tue, 02 Jul 2024 18:26:59 GMT
• cortexyme to host two-part key opinion leader webinar series on atuzaginstat Quantisnow Tue, 02 Jul 2024 18:25:51 GMT
• cortexyme announces leadership appointments to support advancement of atuzaginstat and pipeline expansion Quantisnow Tue, 02 Jul 2024 17:45:55 GMT
• cortexyme to present at 4th annual evercore isi healthconx conference on november 30th Quantisnow Tue, 02 Jul 2024 17:37:08 GMT
• cortexyme to present at canaccord genuity' s 41st annual growth conference on august 11th Quantisnow Tue, 02 Jul 2024 17:35:27 GMT
• cortexyme to present at annual biomarkers for alzheimer's disease summit Quantisnow Tue, 02 Jul 2024 17:25:39 GMT
• do institutions own cortexyme, inc. (nasdaq:crtx) shares? Yahoo New Zealand News Wed, 26 Jun 2024 16:01:00 GMT
• is the options market predicting a spike in cortexyme (crtx) stock? Yahoo New Zealand News Wed, 26 Jun 2024 16:01:00 GMT
• do institutions own cortexyme, inc. (nasdaq:crtx) shares? Yahoo New Zealand News Thu, 20 Jun 2024 04:56:00 GMT
• is the options market predicting a spike in cortexyme (crtx) stock? Yahoo Movies UK Sun, 02 Jun 2024 14:35:01 GMT
• is the options market predicting a spike in cortexyme (crtx) stock? Yahoo Movies UK Mon, 27 May 2024 06:28:36 GMT
• is cortexyme (nasdaq:crtx) in a good position to deliver on growth plans? Yahoo Lifestyle Australia Tue, 21 May 2024 11:04:42 GMT
• is cortexyme (nasdaq:crtx) in a good position to deliver on growth plans? Yahoo Lifestyle Australia Mon, 20 May 2024 02:26:00 GMT
• we're not very worried about cortexyme's (nasdaq:crtx) cash burn rate Yahoo Movies Canada Wed, 08 May 2024 02:06:42 GMT
• is the options market predicting a spike in cortexyme (crtx) stock? Yahoo Movies Canada Tue, 02 Apr 2024 19:32:51 GMT
• cortexyme (nasdaq:crtx) shares pass above 200 day moving average of $1.14 Defense World Wed, 27 Mar 2024 07:00:00 GMT
• cortexyme (nasdaq:crtx) stock price passes above 200-day moving average of $1.14 Defense World Tue, 19 Mar 2024 07:00:00 GMT
• cortexyme (nasdaq:crtx) shares pass above 200-day moving average of $1.15 Defense World Sat, 09 Mar 2024 08:26:22 GMT
• cortexyme (nasdaq:crtx) share price passes above 200 day moving average of $1.15 American Banking News Sat, 09 Mar 2024 08:00:00 GMT
• cortexyme (nasdaq:crtx) share price crosses above 200 day moving average of $1.15 AmericanBankingNEWS Fri, 01 Mar 2024 08:40:30 GMT
• cortexyme (nasdaq:crtx) stock price crosses above two hundred day moving average of $1.15 Defense World Fri, 01 Mar 2024 08:39:12 GMT
• cortexyme (nasdaq:crtx) shares pass above 200 day moving average of $1.14 Defense World Thu, 22 Feb 2024 09:39:30 GMT
• critical analysis: springworks therapeutics (nasdaq:swtx) and cortexyme (nasdaq:crtx) Defense World Mon, 29 Jan 2024 06:20:31 GMT
• cortexyme (nasdaq:crtx) shares cross above 200-day moving average of $1.18 Defense World Sat, 06 Jan 2024 08:00:00 GMT
• the cause of alzheimer's may be coming from inside your mouth ScienceAlert Mon, 18 Dec 2023 08:00:00 GMT
• reviewing aptose biosciences (nasdaq:apto) & cortexyme (nasdaq:crtx) Defense World Wed, 06 Dec 2023 07:53:23 GMT
• humacyte (nasdaq:huma) versus cortexyme (nasdaq:crtx) financial analysis Defense World Thu, 30 Nov 2023 07:43:32 GMT
• what to know about new alzheimer's disease treatments Health Matters Wed, 29 Nov 2023 16:22:24 GMT
• top 8 ai stocks under $10 for smart investment opportunities Analytics Insight Sat, 25 Nov 2023 08:00:00 GMT
• descubrimiento científico revela que la causa del alzheimer podría ... Enséñame de Ciencia Sat, 11 Nov 2023 08:00:00 GMT
• killer smile? an oral pathogen increases heart attack damage, study reveals Medical Xpress Thu, 19 Oct 2023 07:00:00 GMT
• schizophrenia market is expected to showcase a significant growth ... GlobeNewswire Tue, 17 Oct 2023 07:00:00 GMT
• frontotemporal dementia treatment drug market to showcase ... GlobeNewswire Mon, 16 Oct 2023 07:00:00 GMT
• charcot-marie-tooth disease market size and share to grow by ... GlobeNewswire Mon, 18 Sep 2023 07:00:00 GMT
• gum disease could trigger dementia, suggests a new study Wales Online Sun, 13 Aug 2023 07:00:00 GMT
• primary surgery vs radiation in oropharyngeal cancer: does one ... Medpage Today Sun, 09 Jul 2023 07:00:00 GMT
• databricks acquires generative ai platform mosaicml for $1.3b Orrick Tue, 27 Jun 2023 07:00:00 GMT
• spotlight − late-stage challengers in parkinson’s disease Evaluate Pharma Tue, 13 Jun 2023 07:00:00 GMT
• alzheimer's disease clinical trial pipeline insights | 150+ key ... Medgadget Tue, 06 Jun 2023 07:00:00 GMT
• updated: quince adopts 'poison pill' to fend off buyout bid as investor builds stake Fierce Biotech Thu, 06 Apr 2023 07:00:00 GMT
• disgraced former seagen ceo tapped to lead morphimmune less ... FierceBiotech Thu, 23 Mar 2023 07:00:00 GMT
• cortexyme (nasdaq:crtx) & genocea biosciences (nasdaq:gncaq) critical survey 富途牛牛 Wed, 01 Mar 2023 08:00:00 GMT
• 3 more biotechs announce layoffs as industry cost-cutting continues BioPharma Dive Wed, 01 Feb 2023 08:00:00 GMT
• after pivoting from alzheimer's to bone conditions, biotech pivots again — and halves its headcount Endpoints News Tue, 31 Jan 2023 08:00:00 GMT
• Quince lays off 47% of staff, stakes sale sign for asset days after separate pipeline deal Fierce Biotech Mon, 30 Jan 2023 08:00:00 GMT
• quince to lay off nearly half of team, sell more assets Fierce Biotech Mon, 30 Jan 2023 08:00:00 GMT
• Quince's former leadership returns to scoop up unwanted Alzheimer's assets Fierce Biotech Fri, 27 Jan 2023 08:00:00 GMT
• Casey Lynch and her Cortexyme team regroup at Lighthouse for another shot at Alzheimer's The Business Journals Fri, 27 Jan 2023 08:00:00 GMT
• quince therapeutics completes the sale of legacy protease inhibitor portfolio to lighthouse pharmaceuticals Business Wire Fri, 27 Jan 2023 08:00:00 GMT
• quince's former leaders return for unwanted alzheimer's assets Fierce Biotech Fri, 27 Jan 2023 08:00:00 GMT
• casey lynch and her cortexyme team regroup for another shot at alzheimer's - san francisco business times The Business Journals Fri, 27 Jan 2023 08:00:00 GMT
• fierce biotech layoff tracker 2023: gilead's kite cuts 7% in refocus ... FierceBiotech Mon, 09 Jan 2023 19:24:18 GMT
• fda grants full approval for new alzheimer's disease treatment Health Matters Fri, 06 Jan 2023 21:58:59 GMT
• cassava sciences: 3 factors dictating alzheimer drug developer's ... Seeking Alpha Wed, 28 Dec 2022 08:00:00 GMT
• keystone bio linking oral health with systemic benefit BioWorld Online Mon, 05 Dec 2022 08:00:00 GMT
• ctad 2022 – gantenerumab’s shortcomings keep amyloid hypothesis alive Evaluate Pharma Thu, 01 Dec 2022 08:00:00 GMT
• the cause of alzheimer's could be coming from inside your mouth ScienceAlert Tue, 22 Nov 2022 08:00:00 GMT
• alzheimer's disease: oral bacteria may be responsible for illness, says study NDTV Tue, 22 Nov 2022 08:00:00 GMT
• porphyromonas gingivalis in alzheimer's disease brains: evidence for disease causation and treatment with small ... Science Sat, 15 Oct 2022 01:10:34 GMT
• blake masters, peter thiel sought new fda boss, new approach to ... The Arizona Republic Fri, 23 Sep 2022 07:00:00 GMT
• beyond headlines and amyloid, the alzheimer's pipeline chugs along FierceBiotech Thu, 01 Sep 2022 07:00:00 GMT
• zelluna immunotherapy receives investment from takeda ventures FinSMEs Thu, 25 Aug 2022 07:00:00 GMT
• the safety of pimavanserin for parkinson's disease and efforts to ... Am J Psychiatry Wed, 03 Aug 2022 07:00:00 GMT
• COR588, New Gingipain Inhibitor, Safe To Take Once Daily |... Alzheimer's News Today Tue, 02 Aug 2022 07:00:00 GMT
• Quince hoping to sweeten its fruit with acquisitions, out-licensing of legacy Cortexyme assets Fierce Biotech Mon, 01 Aug 2022 07:00:00 GMT
• quince hoping to sweeten its fruit with new strategic plan Fierce Biotech Mon, 01 Aug 2022 07:00:00 GMT
• cortexyme tanks after bacterial protease inhibitor fails alzheimer's trial FirstWord Pharma Fri, 29 Jul 2022 20:16:31 GMT
• cortexyme, inc. - common stock (nasdaq:crtx) stock quote FinancialContent Fri, 29 Jul 2022 07:00:00 GMT
• Cortexyme concludes Phase I Alzheimer’s disease trial Clinical Trials Arena Thu, 28 Jul 2022 07:00:00 GMT
• cortexyme concludes phase i alzheimer's disease trial Clinical Trials Arena Thu, 28 Jul 2022 07:00:00 GMT
• Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 Stock Titan Wed, 27 Jul 2022 07:00:00 GMT
• cortexyme successfully completes phase 1 single and multiple ascending dose clinical trial of cor588 Business Wire Wed, 27 Jul 2022 07:00:00 GMT
• crtx stock on watch as company plans name change (nasdaq:crtx) Seeking Alpha Wed, 27 Jul 2022 07:00:00 GMT
• what is the market's view on cortexyme inc (crtx) stock's price and volume trends thursday? InvestorsObserver Thu, 21 Jul 2022 07:00:00 GMT
• cortexyme announces preclinical data demonstrating efficacy of cor803 for the treatment of coronavirus infections Business Wire Tue, 21 Jun 2022 07:00:00 GMT
• contact - the lethbridge herald - news and sports from around lethbridge FinancialContent Mon, 13 Jun 2022 07:00:00 GMT
• can cortexyme inc (crtx) stock rise to the top of healthcare sector friday? InvestorsObserver Fri, 03 Jun 2022 07:00:00 GMT
• does cortexyme inc (crtx) have what it takes to be in your portfolio tuesday? InvestorsObserver Tue, 31 May 2022 07:00:00 GMT
• cortexyme : statement of changes in beneficial ownership (form 4) MarketScreener Mon, 23 May 2022 07:00:00 GMT
• cortexyme successfully completes acquisition of novosteo Business Wire Fri, 20 May 2022 07:00:00 GMT
• international conference on porphyromonas gingivalis and related species in oral and systemic diseases Business Wire Thu, 12 May 2022 07:00:00 GMT
• Cortexyme shakes things up with Novosteo acquisition, leadership change and a new name Fierce Biotech Tue, 10 May 2022 07:00:00 GMT
• Cortexyme Charts New Course with Acquisition of Rare Disease Player BioSpace Tue, 10 May 2022 07:00:00 GMT
• cortexyme agrees to acquire biotech company novosteo (nasdaq:crtx) Seeking Alpha Tue, 10 May 2022 07:00:00 GMT
• cortexyme acquires novosteo, rebrands with new leadership Fierce Biotech Tue, 10 May 2022 07:00:00 GMT
• is cortexyme (nasdaq:crtx) in a good position to deliver on growth plans? Yahoo Finance Fri, 06 May 2022 07:00:00 GMT
Cortexyme, Inc(NASDAQ:CRTX) 
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase I...
Website: http://www.cortexyme.com
Founded: 2012
Full Time Employees: 37 (May 2021)
CEO: Casey Crawford Lynch
Sector: Healthcare
Industry: Biotechnology